Association between Statin Use and Sepsis Risk in Patients with Dementia: A Retrospective Cohort Study.
Liang-Tsai YehChuan-Yi TangChiao-Wen LinHan-Wei YehYing-Tung YehYu-Hsun WangMing-Chih ChouChao-Bin YehChi-Ho ChanPublished in: International journal of environmental research and public health (2019)
This study investigated the association of statin use with sepsis risk in patients with dementia. This retrospective cohort study was conducted in Taiwan by using data from the National Health Insurance Research Database. We identified and enrolled 308 patients with newly diagnosed dementia who used statin after dementia diagnosis. These patients were individually propensity score matched (1:1) according to age, sex, hypertension, hyperlipidemia, diabetes, cerebrovascular disease, renal disease, liver disease, asthma, malignancy, parkinsonism, and dementia drugs used (donepezil, rivastigmine, galantamine, and memantine) with 251 controls (statin non-users). A Cox proportional hazard model was used to estimate the adjusted hazard ratio for sepsis in statin users and non-users. After adjustment for other confounding factors, the incidence of sepsis in statin users was 1.42-fold higher than that in non-users (95% confidence interval = 0.81-2.5). In conclusion, our analysis showed no positive association of sepsis with statin use in patients with dementia.
Keyphrases
- mild cognitive impairment
- cardiovascular disease
- cognitive impairment
- newly diagnosed
- coronary artery disease
- acute kidney injury
- septic shock
- intensive care unit
- health insurance
- low density lipoprotein
- blood pressure
- ejection fraction
- metabolic syndrome
- air pollution
- high fat diet
- single molecule
- atomic force microscopy
- high resolution
- big data
- deep brain stimulation